Evidence map›Paper›PMID 33308845›Full record

ArticleRevista espanola de geriatria y gerontologia

[Prevalence of SARS-CoV-2 coronavirus infection in patients and professional staff at a medium or long-stay hospital in Spain].

Luis Antonio Moreno Borraz, Mercedes Giménez López, Patricia Carrera Lasfuentes, Emilio González Pérez, Concepción Ortíz Domingo, José Luis Bonafonte Marteles, Carmen Vicente Gaspar, Francisco Amorós de la Nieta, Alejandro Sastre Heres, Ángel Luis García Forcada and 24 more

Open access · greenAbstract read
In one paragraph

Article in Revista espanola de geriatria y gerontologia. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.2field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Observational
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors at 1 institution in 1 country.

Luis Antonio Moreno BorrazLaboratorio de Microbiología, Hospital San Juan de Dios, Zaragoza, España. Electronic address: lamoreno@ohsjd.es.
Mercedes Giménez LópezUnidad de Docencia, Investigación, Hospital San Juan de Dios, Zaragoza, España.
Patricia Carrera LasfuentesCIBER de Enfermedades Hepáticas y Digestivas (CIBEREHD) , Zaragoza, España.
Emilio González PérezGeriatría, Hospital San Juan de Dios, Zaragoza, España.
Concepción Ortíz DomingoGeriatría, Hospital San Juan de Dios, Zaragoza, España.
José Luis Bonafonte MartelesGeriatría, Hospital San Juan de Dios, Zaragoza, España.
Carmen Vicente GasparGerencia, Hospital San Juan de Dios, Zaragoza, España.
Francisco Amorós de la NietaDirección, Hospital San Juan de Dios, Zaragoza, España.
Alejandro Sastre HeresFarmacia, Hospital San Juan de Dios, Zaragoza, España.
Ángel Luis García ForcadaMedicina Interna, Hospital San Juan de Dios, Zaragoza, España.
María Pilar Serrano HerreroMedicina Interna, Hospital San Juan de Dios, Zaragoza, España.
Silvia Fernández DobladoGeriatría, Hospital San Juan de Dios, Zaragoza, España.
María Carmen Espinosa ValGeriatría, Hospital San Juan de Dios, Zaragoza, España.
María Mar Fernández AdarveServicio de Admisión, Hospital San Juan de Dios, Zaragoza, España.
Adriana Narvión CarriquiriGeriatría, Hospital San Juan de Dios, Zaragoza, España.
Fernando Arto MazaGeriatría, Hospital San Juan de Dios, Zaragoza, España.
Marta Barea GilEnfermería, Hospital San Juan de Dios, Zaragoza, España.
Irene Aznar VázquezEnfermería, Hospital San Juan de Dios, Zaragoza, España.
Raquel Sisas RubioEnfermería, Hospital San Juan de Dios, Zaragoza, España.
Raquel González TejedorEnfermería, Hospital San Juan de Dios, Zaragoza, España.
Evelyn Florentín OstárizEnfermería, Hospital San Juan de Dios, Zaragoza, España.
Consuelo López SantedEnfermería, Hospital San Juan de Dios, Zaragoza, España.
Ana Rosa Molina MoralesEnfermería, Hospital San Juan de Dios, Zaragoza, España.
Sara Parrilla BinuéEnfermería, Hospital San Juan de Dios, Zaragoza, España.
Javier Pérez SansUnidad de riesgos Laborables, Hospital San Juan de Dios, Zaragoza, España.
Mercedes García MenaUnidad de Hemodiálisis, Hospital San Juan de Dios, Zaragoza, España.
Belén Moragrega CardonaUnidad de Hemodiálisis, Hospital San Juan de Dios, Zaragoza, España.
Marta Luzón AlonsoUnidad de Hemodiálisis, Hospital San Juan de Dios, Zaragoza, España.
Francisco Díaz MoraMedicina MF y C, Hospital San Juan de Dios, Zaragoza, España.
Juan Carlos Gil AcebesMedicina MF y C, Hospital San Juan de Dios, Zaragoza, España.
Yolanda Rubio MorillaServicio de Admisión, Hospital San Juan de Dios, Zaragoza, España.
Rosa Lou LouMedicina MF y C, Hospital San Juan de Dios, Zaragoza, España.
Rosa Blanca Zabala LahozMedicina MF y C, Hospital San Juan de Dios, Zaragoza, España.
Ana Coarasa Lirón de RoblesUnidad de Neurorrehabilitación, Hospital San Juan de Dios, Zaragoza, España.
Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and goalsThe aim of the study is to know the prevalence of SARS-CoV-2 infection in patients and professional staff of a medium or long-stay hospital during the peak period of the pandemic in Spain, spring 2020. MATERIAL AND

methodsAt the end of February 2020, we developed at the hospital a strategy to diagnose the SARS-CoV-2 infection consisting of complementing the realization of PCR tests at real time with a quick technique of lateral flow immunochromatography to detect IgG and IgM antibodies against the virus. We also developed a protocol to realize those diagnostic tests and considered an infection (current or past) a positive result in any of the above tests. We included 524 participants in the study (230 patients and 294 hospital staff), and divided them into hospital patients and Hemodialysis outpatients. Furthermore, we divided the hospital staff into healthcare and non-healthcare staff. The documented period was from March, 20

results26 out of 230 patients tested positive in any of the diagnostic techniques (PCR, antibodies IgG, IgM) with a 11.30% prevalence. According to patients groups, we got a 14.38% prevalence in hospital patients vs. 5.95% in outpatients, with a significantly higher risk in admitted patients after adjustment for age and gender (OR=3,309, 95%CI: 1,154-9,495). 24 out of 294 hospital staff tested positive in any of the diagnostic techniques, with a 8.16% prevalence. According to the groups, we got a 8.91% prevalence in healthcare staff vs. 4.26% in non-healthcare staff. Thus, we do not see any statistically significant differences between hospital staff and patients as far as prevalence is concerned (P=0,391), (OR=2,200, 95%CI: 0,500-9,689).

conclusionsThe result of the study was a quite low prevalence rate of SARS-CoV-2 infection, in both patients and hospital staff, being the hospital patients' prevalence rate higher than the outpatients', and the healthcare staff higher than the non-healthcare's. Combining PCR tests (gold standard) with antibodies tests proved useful as a diagnostic strategy.

Indexed as

Personnel, HospitalAdultAgedAged, 80 and overCOVID-19FemaleHospitalizationHospitalsHumansMaleMiddle AgedOccupational DiseasesPrevalenceSpainYoung AdultAntibodiesAnticuerposHospital media y larga estanciaMedium or long-stay hospitalPCRPrevalencePrevalenciaSARS-CoV-2

Identifiers

PMID33308845
PMCPMC7664346
OpenAlexW3104152469

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.